Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance

被引:10
作者
Durante-Mangoni, Emanuele [1 ,2 ]
Zarrilli, Raffaele
机构
[1] Univ Naples 2, Monaldi Hosp, Chair Internal Med, Naples, Italy
[2] Univ Naples 2, Monaldi Hosp, Unit Transplant Med, Naples, Italy
关键词
Acinetobacter baumannii; antimicrobial therapy; antiseptics; infection control; molecular epidemiology; resistance genes; VENTILATOR-ASSOCIATED PNEUMONIA; IN-VITRO ACTIVITY; GRAM-NEGATIVE BACTERIA; CRITICALLY-ILL PATIENTS; BORNE BLA(OXA-58) GENE; MULTIDRUG EFFLUX PUMP; INTENSIVE-CARE-UNIT; BETA-LACTAMASE; INTRAVENOUS COLISTIN; PSEUDOMONAS-AERUGINOSA;
D O I
10.2217/FMB.11.23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Acinetobacter baumannii is an opportunistic Gram-negative pathogen with increasing relevance in a variety of hospital-acquired infections especially among intensive care unit patients. Resistance to antimicrobial agents is the main reason for A. baumannii spread. A. baumannii outbreaks described worldwide are caused by a limited number of genotypic clusters of multidrug-resistant strains that successfully spread among hospitals of different cities and countries. In this article, we will focus on the mechanisms responsible for resistance to antimicrobials and disinfectants in A. baumannii and the epidemiology of drug-resistant A. baumannii in healthcare facilities. We will also discuss the therapeutic and infection control strategies for management of drug-resistant A. baumannii epidemics.
引用
收藏
页码:407 / 422
页数:16
相关论文
共 50 条
  • [41] Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
    Durante-Mangoni, Emanuele
    Signoriello, Giuseppe
    Andini, Roberto
    Mattei, Annunziata
    De Cristoforo, Maria
    Murino, Patrizia
    Bassetti, Matteo
    Malacarne, Paolo
    Petrosillo, Nicola
    Galdieri, Nicola
    Mocavero, Paola
    Corcione, Antonio
    Viscoli, Claudio
    Zarrilli, Raffaele
    Gallo, Ciro
    Utili, Riccardo
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (03) : 349 - 358
  • [42] Efficacy and Safety Profile Comparison of Colistin and Tigecycline on the Extensively Drug Resistant Acinetobacter baumannii
    Kwon, Sung Hee
    Ahn, Hye Lim
    Han, Ok Yeon
    La, Hyen O.
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (03) : 340 - 346
  • [43] Global genomic epidemiology of chromosomally mediated non-enzymatic carbapenem resistance in Acinetobacter baumannii: on the way to predict and modify resistance
    Nageeb, Wedad M.
    AlHarbi, Nada
    Alrehaili, Amani A.
    Zakai, Shadi A.
    Elfadadny, Ahmed
    Hetta, Helal F.
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [44] Clinical and molecular epidemiological characterization of extensively drug-resistant Acinetobacter baumannii in patients with liver disease
    Yu, Yanhua
    Chen, Ming
    Lou, Jinli
    Su, Jianrong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 13127 - 13134
  • [45] Successful management of nosocomial ventriculitis and meningitis caused by extensively drug-resistant Acinetobacter baumannii in Austria
    Hoenigl, M.
    Drescher, M.
    Feierl, G.
    Valentin, T.
    Zarfel, G.
    Seeber, K.
    Krause, R.
    Grisold, A. J.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2013, 24 (03) : E88 - E90
  • [46] WGS-Based Analysis of Carbapenem-Resistant Acinetobacter baumannii in Vietnam and Molecular Characterization of Antimicrobial Determinants and MLST in Southeast Asia
    Wareth, Gamal
    Linde, Joerg
    Nguyen, Ngoc H.
    Nguyen, Tuan N. M.
    Sprague, Lisa D.
    Pletz, Mathias W.
    Neubauer, Heinrich
    ANTIBIOTICS-BASEL, 2021, 10 (05):
  • [47] In Vitro Activity of Tigecycline Against Acinetobacter baumannii: Global Epidemiology and Resistance Mechanisms
    Pournaras, Spyros
    Koumaki, Vasiliki
    Gennimata, Vasiliki
    Kouskouni, Evangelia
    Tsakris, Athanassios
    ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 1, 2016, 897 : 1 - 14
  • [48] Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates
    Kiratisin, Pattarachai
    Apisarnthanarak, Anucha
    Kaewdaeng, Srirumpa
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (03) : 243 - 246
  • [49] Pan Drug-Resistant Environmental Isolate of Acinetobacter baumannii from Croatia
    Goic-Barisic, Ivana
    Music, Martina Seruga
    Kovacic, Ana
    Tonkic, Marija
    Hrenovic, Jasna
    MICROBIAL DRUG RESISTANCE, 2017, 23 (04) : 494 - 496
  • [50] Rapid control of a hospital-wide outbreak caused by extensively drug-resistant OXA-72-producing Acinetobacter baumannii
    Lin, Wei-Ru
    Lu, Po-Liang
    Siu, Leung-Kei
    Chen, Tun-Chieh
    Lin, Chun-Yu
    Hung, Ching-Tzu
    Chen, Yen-Hsu
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2011, 27 (06) : 207 - 214